| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Across the recent three months, 12 analysts have shared their insights on Rapid7 (NASDAQ:RPD), expressing a variety of opinions spanning from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 1 | 8 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 2 | 1 | 7 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $25.67, a high estimate of $34.00, and a low estimate of $18.00. Highlighting a 19.98% decrease, the current average has fallen from the previous average price target of $32.08.
A clear picture of Rapid7's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Roger Boyd | UBS | Lowers | Buy | $29.00 | $34.00 |
| Erin Wilson | Morgan Stanley | Lowers | Equal-Weight | $22.00 | $28.00 |
| Fatima Boolani | Citigroup | Lowers | Buy | $30.00 | $35.00 |
| Michael Walkley | Canaccord Genuity | Lowers | Hold | $32.00 | $39.00 |
| Patrick Colville | Scotiabank | Lowers | Sector Perform | $20.00 | $29.00 |
| Anne Meisner | Susquehanna | Lowers | Neutral | $18.00 | $30.00 |
| Roger Boyd | UBS | Lowers | Buy | $34.00 | $39.00 |
| Matthew Hedberg | RBC Capital | Lowers | Sector Perform | $23.00 | $27.00 |
| Adam Tindle | Raymond James | Lowers | Outperform | $30.00 | $40.00 |
| Adam Borg | Stifel | Lowers | Hold | $22.00 | $29.00 |
| Gregg Moskowitz | Mizuho | Lowers | Neutral | $25.00 | $27.00 |
| Brian Essex | JP Morgan | Lowers | Neutral | $23.00 | $28.00 |
For valuable insights into Rapid7's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Rapid7 analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Rapid7 displayed positive results in 3M. As of 30 June, 2025, the company achieved a solid revenue growth rate of approximately 2.98%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Rapid7's net margin excels beyond industry benchmarks, reaching 3.89%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Rapid7's ROE excels beyond industry benchmarks, reaching 11.65%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Rapid7's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.51%, the company showcases efficient use of assets and strong financial health.
Debt Management: Rapid7's debt-to-equity ratio is notably higher than the industry average. With a ratio of 10.7, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: RPD
